Cargando…
Stem Cell Therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury
Extensive clinical efforts have been made to control the severity of dengue diseases; however, the dengue morbidity and mortality have not declined. Dengue virus (DENV) can infect and cause systemic damage in many organs, resulting in organ failure. Here, we present a novel report showing a tailored...
Autores principales: | Sakinah, S., Priya, Sivan Padma, Mok, Pooi Ling, Munisvaradass, Rusheni, Teh, Seoh Wei, Sun, Zhong, Alzahrani, Badr, Abu Bakar, Faizal, Chee, Hui-yee, Awang Hamat, Rukman, He, Guozhong, Xiong, Chenglong, Joseph, Narcisse, Tong, Jia Bei, Wu, Xiaoyun, Maniam, Mahendran, Samrot, Antony V., Higuchi, Akon, Kumar, S. Suresh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287336/ https://www.ncbi.nlm.nih.gov/pubmed/34291043 http://dx.doi.org/10.3389/fcell.2021.637270 |
Ejemplares similares
-
Corrigendum: Stem Cell Therapy in Dengue Virus-Infected BALB/C Mice Improves Hepatic Injury
por: Sakinah, S., et al.
Publicado: (2022) -
Stem Cell Therapy for Treatment of Ocular Disorders
por: Sivan, Padma Priya, et al.
Publicado: (2016) -
Recent Developments in β-Cell Differentiation of Pluripotent Stem Cells Induced by Small and Large Molecules
por: Kumar, S. Suresh, et al.
Publicado: (2014) -
Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe(3)O(4) nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug
por: Krishnan, Poorani, et al.
Publicado: (2017) -
Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells
por: Munisvaradass, Rusheni, et al.
Publicado: (2017)